Can a white blood cell booster heal a rare skin emergency?
NCT ID NCT02739295
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether G-CSF (a drug that boosts white blood cells) can help heal toxic epidermal necrolysis, a rare but severe skin reaction. Ten patients were randomly assigned to receive G-CSF or a placebo for five days. Researchers measured how fast the skin healed and looked at immune cell changes in the skin.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- G-CSF (Neupogen)
- What this could lead to
- If it works, G-CSF could speed up skin healing and improve outcomes for people with this rare, life-threatening skin condition.
- What could go wrong
- This is a very small trial (10 people) and results may not apply to all patients. G-CSF can cause side effects like bone pain or spleen enlargement.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STEVENS-JOHNSON SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Burn Centre of the University Hospital of Liège
Liège, 4000, Belgium
-
IMTR Burn Centre
Loverval, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Eye surgery breakthrough? tiny trial tests humira injection during corneal implant
- Could a simple ingredient boost dry eye drops?
- Planned study on severe skin reactions withdrawn before starting
- Contact lens coating replenisher tested for rare eye conditions
- Small study tests drug for rare, Life-Threatening skin condition
- Arthritis drug shows promise for rare, Life-Threatening skin conditions